Product details
Origins
ADREX 1:25 CBD Extract is a medical cannabis oil that has been extracted from ADREX High CBD Sativa strain.
Composition
ADREX 1:25 CBD Extract contains a CBD level of 25mg and a THC level of less than 1mg per 1 ml. ADREXpharma uses MCT oil as the carrier oil for this ADREX 1:25 CBD Extract. MCT (medium-chain triglycerides) are saturated fats that are easily digested by the human body. When added to cannabis medical oil, MCT can boost the bioavailability of cannabinoids. MCT oil is usually extracted from coconut oil or palm kernel oil and is odourless and tasteless.
Storage
Storing your cannabis product correctly will prolong its life. Keep it in a cool, dry place and away from sunlight. It’s essential to keep this product (and any cannabinoid product) out of the reach of children and animals.
Dosing guidelines
The guidance provided here is not intended to be medical advice – patients will discuss their dosage guidelines with a medical professional independently before beginning their treatment.
This medical cannabis product can be administered sublingually (putting drops under the tongue) or orally ( added to food and drinks).
When using cannabis medical products for the first time, the patient should start with a low dose and gradually increase until they find their optimal dosage. Users should also wait for about 90 minutes for the product to take effect, but it could take longer depending on a range of factors. When administered sublingually, the onset time is between 10-20 minutes, and the effect typically lasts between 4-6 hours. If a patient chooses oral administration, the onset time is 1-2 hours and the duration of action is between 6-10 hours due to the metabolic process in the digestive system. Also, factors like age, weight, lifestyle and body fat percentage (to name a few) can decrease or increase these time.
Extraction
ADREX 1:25 CBD Extract is a medical cannabis oil that has been extracted from ADREX High CBD Sativa strain using ethanol extraction technique. Ethanol is efficient in extracting cannabinoids from the plant material and is regarded as safe by the FDA.
Lab testing
The ADREXpharma company values patient’s safety and therefore engages in third-party lab testing. This practice ensures unbiased and independent results confirmed by a laboratory that’s not associated with the manufacturer. This guarantees accurate information about the product’s chemical composition and the absence of harmful ingredients.
Disclaimer
None of the information given in this product description should be viewed as a treatment option or medical advice. Patients should seek professional advice for further information about medical cannabis products.
